Neutrophil Priming in Trauma and Sepsis
Neutrophil Priming in Trauma and Sepsis
批准号:
7933278
负责人:
MICHAEL B YAFFE
金额:
$24.13万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-30 至 2012-08-31
关键词:
1-Phosphatidylinositol 3-KinaseAcuteAcute Lung InjuryAdultAdult Respiratory Distress SyndromeBindingBiochemicalBiochemistryCause of DeathCellsCellular biologyComplexCritical IllnessCytochromesCytoplasmCytoskeletonCytosolDataDevelopmentEventFundingGoalsHumanInflammatoryInjuryIntensive Care UnitsKnowledgeLipidsMAP Kinase GeneMAPK14 geneMediatingMembraneModelingMolecularMonomeric GTP-Binding ProteinsMorbidity - disease rateMusNADPH OxidaseOrgan failureOxidasesPathogenesisPathway interactionsPatientsPhagocytesPhosphotransferasesPlayPrevention strategyProcessProductionProtein Binding DomainProtein KinaseProteinsPublic HealthReactive Oxygen SpeciesReagentRegulationResearchRespiratory BurstRestRiskRoleSepsisSeriesSignal PathwaySuperoxidesSurgical Intensive CareSyndromeTherapeuticTherapeutic AgentsTissuesTraumaWorkbasecytochrome b558cytokinedesignextracellularhuman CYBA proteinhuman diseaseimprovedin vivokillingslung injurymicrobialmonomermortalitymouse modelneutrophilneutrophil cytosol factor 40Kneutrophil cytosol factor 67Knovel diagnosticspathogenprotein protein interaction
中文摘要
描述(申请人提供):创伤和脓毒症后中性粒细胞的启动和激活是导致成人呼吸窘迫综合征(ARDS)、急性肺损伤(ALI)和多器官衰竭综合征(MOSF)的关键事件。在损伤和脓毒症后,细胞因子启动呼吸爆发会导致NADPH氧化酶产生过量的超氧化物,从而导致自体炎症组织损伤。然而,涉及NADPH氧化酶的启动和激活的许多分子机制仍然不清楚。我们的长期目标是从分子水平上详细了解蛋白激酶和脂激酶信号通路,包括PI3-激酶通路、p38MAPK通路和ERK1/2通路,在启动和激活过程中如何调节中性粒细胞NADPH氧化酶的组装、亚细胞靶向和活性。我们以前的工作和初步观察发现,p47Phox和p40Phox亚基中的Px结构域是与PI 3-激酶的特定脂类产物结合的模块蛋白结构域,并表明启动剂PAF和TNF1诱导了p47Phox:p67Phox:p40Phox异源三聚体在启动但未激活的细胞胞浆中的组装。在这项研究中,我们使用生物化学、细胞生物学和小鼠模型研究了px结构域介导的与脂质和细胞骨架的相互作用,以及p47Phox与含有PDZ结构域的蛋白质的结合在中性粒细胞启动和激活中的重要性。此外,我们还进一步探讨了启动过程中异源三聚体形成过程中依赖蛋白激酶的分子机制。这些研究的结果可能有助于开发新的诊断或治疗试剂,旨在限制患者因脓毒症和创伤而遭受的自体炎症组织损害。创伤和脓毒症后中性粒细胞的启动和激活是导致成人呼吸窘迫综合征(ARDS)、急性肺损伤(ALI)和多器官衰竭综合征(MOSF)的关键事件,这些都是成人外科重症监护病房的主要死亡原因。在损伤和脓毒症后,细胞因子启动中性粒细胞呼吸爆发,导致NADPH氧化酶产生过量的超氧化物,并导致这些综合征中出现的自体炎症组织损伤。我们的研究旨在更好地了解创伤和脓毒症后NADPH氧化酶的调节,并促进新型诊断和治疗药物的开发,以减少这些危重患者的组织损伤、发病率和死亡率。
英文摘要
DESCRIPTION (provided by applicant): Neutrophil priming and activation following trauma and sepsis is a key event implicated in causing Adult Respiratory Distress Syndrome (ARDS), Acute Lung Injury (ALI) and Multi-Organ Failure Syndrome (MOSF). Priming of the respiratory burst by cytokines following injury and sepsis results in excessive superoxide production by the NADPH oxidase leading to auto-inflammatory tissue damage. Many of the molecular mechanisms involved in priming and activation of the NADPH oxidase, however, remain poorly defined. Our long-term goal is to develop a detailed molecular understanding of how protein kinase and lipid kinase signaling pathways, including the PI 3-kinase pathway, the p38MAPK pathway and the Erk1/2 pathways regulate the assembly, subcellular targeting, and activity of the neutrophil NADPH oxidase during priming and activation. Our previous work and preliminary observations identified PX domains in the p47phox and p40phox subunits as modular protein domains that bind to specific lipid products of PI 3-kinase, and showed that the priming agents PAF and TNF1 induced the assembly of a p47phox:p67phox:p40phox heterotrimeric complex in the cytoplasm of primed but un-activated cells. In the studies outlined in this proposal we investigate the importance of PX domain-mediated interactions with lipids and the cytoskeleton, and p47phox binding to PDZ- domain-containing proteins, in neutrophil priming and activation using biochemistry, cell biology and mouse models. In addition, we further explore protein kinase-dependent molecular mechanisms involved in heterotrimer formation during priming. The results from these studies may assist in the development of novel diagnostic or therapeutic reagents aimed at limiting the auto-inflammatory tissue damage patients suffer as a result of sepsis and trauma. PUBLIC HEALTH RELEVANCE3 Neutrophil priming and activation following trauma and sepsis is a key event implicated in causing Adult Respiratory Distress Syndrome (ARDS), Acute Lung Injury (ALI) and Multi-Organ Failure Syndrome (MOSF), which are the leading causes of death in adult surgical intensive care units. Priming of the neutrophil respiratory burst by cytokines following injury and sepsis results in excessive superoxide production by the NADPH oxidase and contributes to the auto-inflammatory tissue damage seen in these syndromes. Our research is designed to better understand regulation of the NADPH oxidase following trauma and sepsis, and facilitate the development of novel diagnostic and therapeutic agents that will reduce tissue damage, morbidity and mortality in these critically ill patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Protein Kinase Signaling in the Genotoxic Stress Response
-
批准号:9975171
-
项目类别:
-
资助金额:$54.05万
-
财政年份:2017
-
负责人:MICHAEL B YAFFE
-
依托单位:
Protein Kinase Signaling in the Genotoxic Stress Response
-
批准号:10219250
-
项目类别:
-
资助金额:$53.21万
-
财政年份:2017
-
负责人:MICHAEL B YAFFE
-
依托单位:
Protein Kinase Signaling in the Genotoxic Stress Response
-
批准号:10664948
-
项目类别:
-
资助金额:$51.45万
-
财政年份:2017
-
负责人:MICHAEL B YAFFE
-
依托单位:
Protein Kinase Signaling in the Genotoxic Stress Response
-
批准号:9752562
-
项目类别:
-
资助金额:$54.86万
-
财政年份:2017
-
负责人:MICHAEL B YAFFE
-
依托单位:
Protein Kinase Signaling in the Genotoxic Stress Response
-
批准号:10445249
-
项目类别:
-
资助金额:$52.34万
-
财政年份:2017
-
负责人:MICHAEL B YAFFE
-
依托单位:
Biopolymers & Proteomics
-
批准号:9149768
-
项目类别:
-
资助金额:$28.64万
-
财政年份:2015
-
负责人:MICHAEL B YAFFE
-
依托单位:
Phospho-Binding Ligands and Substrates of BRCA1
-
批准号:8413981
-
项目类别:
-
资助金额:$24.08万
-
财政年份:2012
-
负责人:MICHAEL B YAFFE
-
依托单位:
Phospho-Binding Ligands and Substrates of BRCA1
-
批准号:8502497
-
项目类别:
-
资助金额:$19.66万
-
财政年份:2012
-
负责人:MICHAEL B YAFFE
-
依托单位:
Biopolymers & Proteomics
-
批准号:8181146
-
项目类别:
-
资助金额:$21.46万
-
财政年份:2010
-
负责人:MICHAEL B YAFFE
-
依托单位:
DNA Damage Networks
-
批准号:8181035
-
项目类别:
-
资助金额:$34.98万
-
财政年份:2010
-
负责人:MICHAEL B YAFFE
-
依托单位:
STRUCTURE OF THE SIGMA ISOFORM OF THE PHOSPHOPEPTIDE-BINDING PROTEIN 14-3-3
-
批准号:7721199
-
项目类别:
-
资助金额:$0.7万
-
财政年份:2008
-
负责人:MICHAEL B YAFFE
-
依托单位:
PROJECT 7
-
批准号:7695173
-
项目类别:
-
资助金额:$18.85万
-
财政年份:2008
-
负责人:MICHAEL B YAFFE
-
依托单位:
Cell Growth & Proliferation Gordon Research Conference
-
批准号:7332061
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2007
-
负责人:MICHAEL B YAFFE
-
依托单位:
Cell Growth & Proliferation Gordon Research Conference
-
批准号:7452423
-
项目类别:
-
资助金额:$0.6万
-
财政年份:2007
-
负责人:MICHAEL B YAFFE
-
依托单位:
CORE--BIOPOLYMER LABORATORY
-
批准号:7552760
-
项目类别:
-
资助金额:$24.03万
-
财政年份:2007
-
负责人:MICHAEL B YAFFE
-
依托单位:
Cell Growth & Proliferation Gordon Research Conference
-
批准号:7846140
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2007
-
负责人:MICHAEL B YAFFE
-
依托单位:
Protein Kinase Signaling and Cell Cycle Control
-
批准号:8583727
-
项目类别:
-
资助金额:$50.33万
-
财政年份:2006
-
负责人:MICHAEL B YAFFE
-
依托单位:
Protein Kinase Signaling and Cell Cycle Control
-
批准号:8719102
-
项目类别:
-
资助金额:$49.82万
-
财政年份:2006
-
负责人:MICHAEL B YAFFE
-
依托单位:
Protein Kinase Signaling and Cell Cycle Control
-
批准号:7190433
-
项目类别:
-
资助金额:$36.05万
-
财政年份:2006
-
负责人:MICHAEL B YAFFE
-
依托单位:
Protein Kinase Signaling and Cell Cycle Control
-
批准号:8856565
-
项目类别:
-
资助金额:$50.33万
-
财政年份:2006
-
负责人:MICHAEL B YAFFE
-
依托单位:
海外基金